Company intelligence / Profile preview

Advanced Refractive Technologies

San Clemente, California, United States

Ownership: Private
Development stage: Other

Overview

Advanced Refractive Technologies (ART) was a medical device company focused on the development and commercialization of innovative ophthalmic surgical tools for refractive and cataract surgery. The company's flagship product was the Epi-K, a premier epikeratome designed for Epi-LASIK procedures, which allowed surgeons to create a precise epithelial flap without the risks associated with traditional stromal LASIK flaps. ART also developed the Accu-Pulse, a water-jet based surgical system intended for precise tissue separation in various ophthalmic applications. Headquartered in San Clemente, California, the company was publicly traded but has since ceased active operations.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Advanced Refractive Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Refractive Technologies.

Explore the full profile